PortalPublikationenWillingness to pay for a cure of low-risk melanoma patients ...

Willingness to pay for a cure of low-risk melanoma patients in Germany

Standard

Willingness to pay for a cure of low-risk melanoma patients in Germany. / Augustin, Matthias; Blome, Christine; Forschner, Andrea; Gutzmer, Ralf; Hauschild, Axel; Heinzerling, Lucie; Livingstone, Elisabeth; Loquai, Carmen; Schadendorf, Dirk; Utikal, Jochen; Wagner, Tobias; Wilden, S.; Kähler, Katharina.

in: PLOS ONE, Jahrgang 13, Nr. 5, 24.05.2018, S. e0197780.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Augustin, M, Blome, C, Forschner, A, Gutzmer, R, Hauschild, A, Heinzerling, L, Livingstone, E, Loquai, C, Schadendorf, D, Utikal, J, Wagner, T, Wilden, S & Kähler, K 2018, 'Willingness to pay for a cure of low-risk melanoma patients in Germany', PLOS ONE, Jg. 13, Nr. 5, S. e0197780. https://doi.org/10.1371/journal.pone.0197780

APA

Augustin, M., Blome, C., Forschner, A., Gutzmer, R., Hauschild, A., Heinzerling, L., Livingstone, E., Loquai, C., Schadendorf, D., Utikal, J., Wagner, T., Wilden, S., & Kähler, K. (2018). Willingness to pay for a cure of low-risk melanoma patients in Germany. PLOS ONE, 13(5), e0197780. https://doi.org/10.1371/journal.pone.0197780

Vancouver

Augustin M, Blome C, Forschner A, Gutzmer R, Hauschild A, Heinzerling L et al. Willingness to pay for a cure of low-risk melanoma patients in Germany. PLOS ONE. 2018 Mai 24;13(5):e0197780. https://doi.org/10.1371/journal.pone.0197780

Bibtex

@article{802d50ff55224474b2b42ae421cb5bc1,
title = "Willingness to pay for a cure of low-risk melanoma patients in Germany",
abstract = "Malignant melanoma is potentially life-threatening but in most cases curable if detected early. Willingness to pay (WTP) is a preference-based construct that reflects burden of disease by assessment of the monetary value for a hypothetical cure from disease. Since WTP (directly as total amount of money) has not been assessed so far in patients with low risk melanoma, it was interesting to gain insights in this patient population and then, in a second step, compare it directly with the WTP of their treating dermato-oncologists. WTP was assessed in 125 patients with low-risk melanoma and additionally in 105 treating physicians, asking for the one-time and continuous payments they would be willing to make for a sustainable cure, both as absolute sums and as percentages of monthly income. The median WTP based on one-time payment was (sic)10,000 for patients and (sic)100,000 for physicians; relative numbers were 100% versus 300% of monthly income. For continuous monthly payments, WTP was (sic)500 for patients and (sic)1000 for physicians, relative numbers 25% and 50% of income, respectively. Even after controlling for income differences, there was a significantly higher WTP in physicians for all four questions. Compared to patients with chronic skin diseases such as vitiligo, rosacea, atopic eczema and psoriasis, patients with low-risk melanoma showed a significantly higher WTP. Our data suggest that there is a relevant burden of disease even in patients with low-risk tumors. Higher WTP of physicians underlines the prevalence of differences in disease perception.",
keywords = "Adult, Aged, Cost of Illness, Female, Germany, Humans, Income, Male, Melanoma/economics, Middle Aged, Neoplasm Staging, Odds Ratio, Patient Preference, Physicians/psychology, Skin Neoplasms/economics, Surveys and Questionnaires",
author = "Matthias Augustin and Christine Blome and Andrea Forschner and Ralf Gutzmer and Axel Hauschild and Lucie Heinzerling and Elisabeth Livingstone and Carmen Loquai and Dirk Schadendorf and Jochen Utikal and Tobias Wagner and S. Wilden and Katharina K{\"a}hler",
year = "2018",
month = may,
day = "24",
doi = "10.1371/journal.pone.0197780",
language = "English",
volume = "13",
pages = "e0197780",
journal = "PLOS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "5",

}

RIS

TY - JOUR

T1 - Willingness to pay for a cure of low-risk melanoma patients in Germany

AU - Augustin, Matthias

AU - Blome, Christine

AU - Forschner, Andrea

AU - Gutzmer, Ralf

AU - Hauschild, Axel

AU - Heinzerling, Lucie

AU - Livingstone, Elisabeth

AU - Loquai, Carmen

AU - Schadendorf, Dirk

AU - Utikal, Jochen

AU - Wagner, Tobias

AU - Wilden, S.

AU - Kähler, Katharina

PY - 2018/5/24

Y1 - 2018/5/24

N2 - Malignant melanoma is potentially life-threatening but in most cases curable if detected early. Willingness to pay (WTP) is a preference-based construct that reflects burden of disease by assessment of the monetary value for a hypothetical cure from disease. Since WTP (directly as total amount of money) has not been assessed so far in patients with low risk melanoma, it was interesting to gain insights in this patient population and then, in a second step, compare it directly with the WTP of their treating dermato-oncologists. WTP was assessed in 125 patients with low-risk melanoma and additionally in 105 treating physicians, asking for the one-time and continuous payments they would be willing to make for a sustainable cure, both as absolute sums and as percentages of monthly income. The median WTP based on one-time payment was (sic)10,000 for patients and (sic)100,000 for physicians; relative numbers were 100% versus 300% of monthly income. For continuous monthly payments, WTP was (sic)500 for patients and (sic)1000 for physicians, relative numbers 25% and 50% of income, respectively. Even after controlling for income differences, there was a significantly higher WTP in physicians for all four questions. Compared to patients with chronic skin diseases such as vitiligo, rosacea, atopic eczema and psoriasis, patients with low-risk melanoma showed a significantly higher WTP. Our data suggest that there is a relevant burden of disease even in patients with low-risk tumors. Higher WTP of physicians underlines the prevalence of differences in disease perception.

AB - Malignant melanoma is potentially life-threatening but in most cases curable if detected early. Willingness to pay (WTP) is a preference-based construct that reflects burden of disease by assessment of the monetary value for a hypothetical cure from disease. Since WTP (directly as total amount of money) has not been assessed so far in patients with low risk melanoma, it was interesting to gain insights in this patient population and then, in a second step, compare it directly with the WTP of their treating dermato-oncologists. WTP was assessed in 125 patients with low-risk melanoma and additionally in 105 treating physicians, asking for the one-time and continuous payments they would be willing to make for a sustainable cure, both as absolute sums and as percentages of monthly income. The median WTP based on one-time payment was (sic)10,000 for patients and (sic)100,000 for physicians; relative numbers were 100% versus 300% of monthly income. For continuous monthly payments, WTP was (sic)500 for patients and (sic)1000 for physicians, relative numbers 25% and 50% of income, respectively. Even after controlling for income differences, there was a significantly higher WTP in physicians for all four questions. Compared to patients with chronic skin diseases such as vitiligo, rosacea, atopic eczema and psoriasis, patients with low-risk melanoma showed a significantly higher WTP. Our data suggest that there is a relevant burden of disease even in patients with low-risk tumors. Higher WTP of physicians underlines the prevalence of differences in disease perception.

KW - Adult

KW - Aged

KW - Cost of Illness

KW - Female

KW - Germany

KW - Humans

KW - Income

KW - Male

KW - Melanoma/economics

KW - Middle Aged

KW - Neoplasm Staging

KW - Odds Ratio

KW - Patient Preference

KW - Physicians/psychology

KW - Skin Neoplasms/economics

KW - Surveys and Questionnaires

U2 - 10.1371/journal.pone.0197780

DO - 10.1371/journal.pone.0197780

M3 - SCORING: Journal article

C2 - 29795621

VL - 13

SP - e0197780

JO - PLOS ONE

JF - PLOS ONE

SN - 1932-6203

IS - 5

ER -